Nemaura Medical Inc (NMRD)
OTHER OTC:NMRD
US Market
Holding NMRD?
Track your performance easily

Nemaura Medical (NMRD) Income Statement

162 Followers

Nemaura Medical Income Statement

Last quarter (Q3 2024), Nemaura Medical's total revenue was $―, a decrease of -100.00% from the same quarter last year. In Q3, Nemaura Medical's net income was $-2.16M. See Nemaura Medical’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Mar 23Mar 22Mar 21Mar 20Mar 19
Total Revenue
-$ 77.04K$ 503.91K-$ 0.00$ 0.00
Cost of Revenue
-$ 1.55M$ 344.30K---
Gross Profit
$ -1.27M$ -1.48M$ 159.61K---
Operating Expense
$ 8.35M$ 7.14M$ 7.73M$ 4.59M$ 4.78M$ 4.48M
Operating Income
$ -8.85M$ -9.60M$ -7.57M$ -4.59M$ -4.78M$ -4.48M
Net Non Operating Interest Income Expense
$ -5.47M$ -6.41M$ -6.67M$ -2.01M$ 3.93K$ 23.93K
Other Income Expense
$ -1.70M$ 883.96K-$ -472.56K--
Pretax Income
$ -12.63M$ -14.14M$ -14.49M$ -6.12M$ -4.77M$ -4.45M
Tax Provision
$ -338.28K-$ -350.26K$ -335.83K$ -614.36K$ 0.00
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -10.62M$ -14.14M$ -14.14M$ -5.79M$ -4.16M$ -4.45M
Basic EPS
$ -0.78$ -0.57$ -0.59-$ -0.20$ -0.25
Diluted EPS
$ -0.78$ -0.57$ -0.59$ -0.28$ -0.20$ -0.25
Basic Average Shares
$ 111.58M$ 24.88M$ 23.38M$ 22.28M$ 20.81M$ 18.09M
Diluted Average Shares
$ 111.58M$ 24.88M$ 23.38M$ 22.28M$ 20.81M$ 18.09M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 8.35M$ 8.69M$ 8.07M$ 4.59M$ 4.78M$ 4.48M
Net Income From Continuing And Discontinued Operation
$ -10.34M$ -14.14M$ -14.14M$ -5.79M$ -4.16M$ -4.45M
Normalized Income
$ -13.95M$ -9.36M--$ -4.16M$ -4.45M
Interest Expense
------
EBIT
$ -6.06M$ -7.73M$ -7.83M$ -4.11M$ -4.78M$ -4.48M
EBITDA
$ -7.42M$ -7.29M$ -931.88K$ -4.02M$ -4.72M$ -4.44M
Currency in USD

Nemaura Medical Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis